UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

Form 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) January 17, 2017

 

 

 

eWELLNESS HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   90-1073143
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
11825 Major Street, Culver City, California   90230
(Address of principal executive offices)   (Zip Code)

 

(310) 915-9700

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

     
     

 

Item 1.01 Entry into a Material Definitive Agreement

 

On January 17, 2017, eWellness Healthcare Corporation (the “Registrant”), entered into a letter engagement agreement (“Agreement”) with Lyons Capital, LLC, a Florida limited liability company (the “Consultant”) pursuant to which the Consultant will be engaged for a sixth-month period to provide services to the Registrant which will include: (i) introductions to brokers; (ii) assist with research coverage; (iii) introductions to over 100 funds, investment banking firms and market makers (“Investment Professionals”); and (iv) a presentation speaking slot with a Gold sponsorship at the 2017 Wall Street Conference (collectively, the “Services”). In consideration for the Services, the Registrant will issue to the Consultant 75,000 restricted shares of the Registrant’s common stock, par value $0.001 (the “Shares”). A copy of the Agreement is filed as Exhibit 10.20 to this Form 8-K.

 

On November 21, 2016, the Registrant reported on Form 8-K that it had entered into a Services Agreement with Bistromatics, Inc. organized under the laws of Canada (“Bistromatics”). Pursuant to the Services Agreement, which was filed an exhibit to that form 8-K, as consideration for services already completed by Bistromatics on behalf of the Registrant’s Phzio platform, the Registrant agreed to pay a base fee of $50,000 monthly until Bistromatics successfully signed and collected the service fee for 100 Physical Therapy Clinics to start using the PHZIO platform, following which the monthly service fee will increase to $100,000. Bistromatics had the right to convert any outstanding amounts owed by the Registrant into Shares based upon a formula set forth in the Services Agreement. In addition, the Registrant agreed to issue Bistromatics 25,280,899 Shares based upon a price of $0.0089 per Share and granted Bistromatics with the right to appoint 40% of the Board of the Registrant.

 

On January 24, 2017, the Registrant entered into a Definitive Service Agreement with Bistromatics, a copy of which is filed as Exhibit 10.21 hereto, pursuant to which the Parties acknowledged that the Registrant does not currently have a sufficient number of authorized shares of common stock, based upon the number of issued and outstanding shares together with shares reserved for issuance, to issue Bistromatics 25,280,899 shares of common stock. As a result, the Registrant and Bistromatics agreed that the Registrant shall issue 2,5280,899 shares of a newly authorized Series A Preferred Stock to Bistromatics (the “Series A Preferred Stock”) each share of which shall: (i) have 20 votes per share on all matters submitted to the vote of the holders of eWellness voting capital stock (i.e.: 50,577,980 share voting rights); and (ii) be convertible into 10 shares of eWellness existing shares of common stock. Notwithstanding the foregoing, the Series A Preferred Stock shall not be convertible into shares of common stock, until such time as the Company files a Certificate of Amendment to its Articles of Incorporation to increase its authorized shares of common stock from 100 million shares, par value $0.001 per share to 400 million shares, par value $0.0001per share. At the date of filing the Articles of Amendment, the outstanding shares of Series A Preferred Stock must be converted into 25,280,899 shares of the Company’s common stock. Reference is made to the disclosure under Item 5.02 below.

 

Item 3.02 Unregistered Sales of Equity Securities

 

On January 11, 2017, the Registrant reported on Form 8-K that it had entered into a convertible note financing of $55,000 from JEB Partners L.P., effective January 9, 2017. On January 25, 2017, the Registrant received an additional $55,000 in convertible note financing from JPB Partners, which was identical to the January 9, 2017 financing. The new $55,000 convertible note (the “Note”) is convertible into restricted shares of the Registrant’s common stock, par value $0.001, at conversion price into which the principal amount and accrued interest at 8% per annum, equal to the lesser of: (i) $0.20 per share; or (ii) 75% of the average of the VWAPs for the five (5) trading days immediately following the 180th calendar day after the original issue date. The Registrant received $50,000 in proceeds of the $55,000 principal amount of $55,000 Note, and the $5,000 additional principal represents the purchase price less a 10% original issue discount. Although the Registrant has an informal arrange with JEB Partners from which it anticipates up to an additional $1.2 million in convertible note financing, there can be no assurance that additional capital will be invested by JEB partners L.P. at the same terms and conditions, if at all.

 

Item 3.03 Material Modification to Rights of Security Holders.

 

Reference is made to the disclosure in Item 1.01 above. In connection with the Registrant’s obligations under its Agreement with Bistromatics with respect to the issuance of 2,5280,899 shares of a newly authorized class of Series A Preferred Stock, which shall have 20 votes per share on all matters submitted to the vote of the holders of the Registrant’s voting capital stock (i.e.: 50,577,980 share voting rights); and (ii) be convertible into 10 shares of Registrant’s existing shares of common stock, the rights of the holders of the Registrant’s issued and outstanding common stock may be deemed to have been materially limited or qualified by the super voting rights of the Series A Preferred Stock which is about to be issued. This limitation or qualification will be the result of a dilution of the voting rights of the Registrant’s existing holders of common stock.

 

     
     

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

In connection with the Registrant’s obligations under the Definitive Service Agreement dated January 24, 2017, a copy of which it filed as Exhibit 10.21 hereto, the Registrant has agreed to file a Certificate of Amendment to its Articles of Incorporation with the State of Nevada for the purposes of: (A) increasing its authorized capital stock from 110,000,000 shares of capital stock, par value $0.001, consisting of: (i) 100,000,000 shares of common stock, par value $0.001; and (ii) 10,000,000 shares of preferred stock, par value $0.001, to 410,000,000 shares of capital stock, par value $0.0001, consisting of: (iii) 400,000,000 shares of common stock, par value $0.0001; and (iv) 10,000,000 shares of preferred stock, par value $0.0001. The Certificate of Amendment will not be filed with the State of Nevada until the Registrant files an Information Statement on Schedule 14C, based upon the Joint Written Consent of the Registrant’s Board of Directors and the Majority Consenting Stockholders (which term is defined as the holders of a majority of the Registrant’s shares of voting capital stock, including both the Common Stock and Series A Preferred Stock); and (B) implementing a reverse split of the issued and outstanding shares of common stock, including shares of common stock reserved for issuance, in a ratio to be determined by the Registrant’s Board of Directors, not to exceed a one-for-twenty (1:20) basis (the “Reverse Split”). After the Information Statement clears comments with the Securities and Exchange Commission, the Registrant must submit an application to and receive approval from FINRA for these corporate actions.

 

Section 9 – Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.   Description
10.20   Letter Engagement Agreement dated January 17, 2017, between the Registrant and Lyons Capital, LLC, filed herewith.
10.21   Definitive Service Agreement dated January 24, 2017, between the Registrant and Bistromatics, Inc., filed herewith.

 

     
     

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 31, 2017

 

eWellness Healthcare Corporation

 

By: /s/ Darwin Fogt  
Name: Darwin Fogt  
Title: Chief Executive Officer  

 

     
     

 

 

EXHIBIT 10.20

 

January 17, 2017

 

Lyons Capital, LLC (Sophisticated Consulting Services)

7239 San Salvador Dr. - Suite 100

Boca Raton, FL 33433

jason@lyonscapital.com

www.wallstconference.com

 

  Re: Engagement Letter - Effective Date 01/17/17

 

This is to confirm that Lyons Capital, LLC will be retained for consulting services set forth below, by: eWellness Healthcare Corporation. (EWLL or the “Company”) for a sixth-month term commencing on the date hereof:

 

Lyons Capital, LLC (“Lyons Capital” or the “Consultant”) will receive 75,000 restricted Rule 144 shares (the “Shares”) in consideration for Services being rendered.

 

Services rendered will include; Introductions to Brokers, Research coverage, Funds, Investment Banking firms, Market makers and Business developments opportunities (collectively, the “Professionals”). Lyons Capital is not a Broker/Dealer and will not be acting as one. Lyons Capital does not engage in web base, hype promotion.

 

Lyons Capital guarantees at least an introduction to over 100 such Professionals and a presentation speaking slot with a Gold sponsorship at the 2017 Wall Street Conference.

 

The Company undertakes and agrees to use its best efforts to remain compliant in their filings under the Securities Exchange Act of 1934 (the “Exchange Act”) and that Company counsel will issue a Rule 144 opinion after 6 months.

 

The Shares constitute a retainer and commencement incentive and consideration now earned, due and owing to Consultant for entering into this Agreement and allocating its professional time and resources for the benefit of the Company during the Initial Term. The Company acknowledges that Consultant must forego other opportunities to enter into this Agreement. As such, the Shares are deemed irrevocably and fully-earned as of the Effective Date, and any calculation of the statutory holding period for removal of restrictive legend under Rule 144 promulgated under the Securities Act of 1933, shall be measured from the Effective Date of this Agreement.

 

As a condition of accepting these shares for deposit to the account of Lyons Capital LLC carried by your clearing firm, you have requested this letter which serves to confirm the authenticity of the certificates evidencing the Shares referenced above.

 

eWellness Healthcare Corporation confirms that the above-referenced Shares are being/have been issued without encumbrance, are fully paid and non-assessable Shares and upon satisfaction of the six-month holding period set forth in Rule 144(d) will be eligible to have the restrictive legend removed and to be freely tradable. Any restrictive legend currently existing on said Share certificate, upon satisfaction of the aforementioned Rule 144(d) holding period, will be fully eligible to be lifted under the provisions of Section 4(1) of the Securities Act of 1933, as amended (the “Act”) and/or Rule 144 promulgated by the Securities and Exchange Commission under the Act. Further, there is no action, proceeding or investigation pending or threatened which questions the validity of the issuance of the Shares to Lyons Capital LLC or any of the forgoing representations.

 

eWellness Healthcare Corporation hereby acknowledges that for purposes of settling the contemplated sale transaction by Lyons Capital LLC that eWellness Healthcare Corporation has no claims pending that would adversely affect the settlement of any sale transaction engaged in by Lyons Capital LLC. eWellness Healthcare Corporation further acknowledges and agrees that there is no other agreement or understanding between Lyons Capital LLC and eWellness Healthcare Corporation that would preclude Lyons Capital LLC from selling or otherwise disposing of Shares represented above.

 

We look forward to working with you.

 

/s/ Jason S. Lyons  
Jason S Lyons  
Chairman, Lyons Capital LLC  

 

Agreed to and Accepted by  
eWellness Healthcare Corporation, by:  
By: /s/ Darwin Fogt  
Name: Darwin Fogt  
Title: Chief Executive Officer  

 

1

 

 

 

 

EXHIBIT 10.21

 

eWellness Bistromatics Definitive Service Agreement

 

This Definitive Service Agreement (the “Agreement”), is entered into this 24th day of January 2017, by and between eWellness Healthcare Corporation (the “Company”) and Bistromatics, Inc. (“Bistromatics”) and modifies the Service Agreement between the Parties dated November 12, 2016. eWellness and Bistromatics are sometimes referred to hereinafter collectively, as the “Parties” and individually, as a “Party.”

 

Recitals:

 

WHEREAS, on November 12, 2016, the Company and Bistromatics executed a Service Agreement filed as an exhibit to the Company’s Form 8-K dated November 21, 2016; and

 

WHEREAS, during the past four years, both prior and subsequent to the execution of the Service Agreement, he Company has struggled financially in the development of the Company’s PHZIO System; and

 

WHEREAS, as a result of these financial difficulties, the senior management of the Company did not receive any of the agreed to compensation. And further, Bistromatics provided substantial unanticipated additional services during the past 5 months to fully engineer and construct additional novel features that were required in order to ready the PHZIO platform for launch; and

 

WHEREAS, these additional services resulted in costs to Bistromatics in the amount of approximately US$225,000; and

 

WHEREAS, the Company continues to be in a position where it cannot repay Bistromatics for its advances nor pay the monthly fees owed under the service Agreement, nor are the Company’s senior executives willing to continue to work for no compensation; and

 

WHEREAS, as a result of the foregoing, Bistromatics has offered the following solution in order to launch the PHZIO platform

to the entire physical therapy (“PT”) industry in the form of a 3-year Agreement.

 

NOW THEREFORE, the Parties agree as follows in order to further their respective business objectives based upon both Parties belief that this Agreement will lower the long-term costs of operating the PHZIO platform.

 

Section 1. eWellness outsources operational oversight to Bistromatics for the Phzio System

 

  Development
     
  Content Editing
     
  Client on boarding
     
  Clinic Training
     
  Support & Maintenance
     
  Billing
     
  Hosting
     
  Oversight and Support of CRM and Helpdesk system

 

Monthly base fee: $100,000 to be paid by eWellness to Bistromatics for development, content editing, client development and support and covering the compensation costs of Curtis Hollister CTO, Darwin Fogt, CEO and Mike Block, Senior Programmer. Fogt and Hollister will retain their eWellness officer positions and board seats and will retain their past due compensation up through June 30, 2016. All current and future compensation shall be solely though this service agreement.

 

Post payment of the initial $100,000 monthly base fee, eWellness will only be obligated to pay $50,000 monthly until Bistromatics has successfully signed and collected the first monthly service fee for 100 Physical Therapy Clinics to start using the PHZIO platform.

 

A Physical Therapy Clinic is defined as unique physical location where physical therapy services are delivered and a monthly fee is charged to the Clinic to use the PHZIO platform.

 

Bistromatics will provide eWellness notice and evidentiary details to show the 100 Clinics goal has been realized. Upon such notice, the Monthly Base Payment will return to $100,000 and be paid per the existing schedule.

 

1
 

 

eWellness will be responsible for Expenses associated with:

 

  Content creation;
     
  Hosting;
     
  Software licenses fees (e.g.);
     
  Development & support resources
     
  Travel and communications; and
     
  other eWellness specific expenses are to be charged back to eWellness at cost +15%.

 

First Payment Date: On or before November 15, 2016. Bistromatics will have the ability to convert any outstanding amounts that fall in arrears 60 days into common stock at the same terms as the next round of financing or the Company’s common stock price, whichever is higher.

 

Payments for Monthly Base Fees will be issued on the 10th calendar day of each month. eWellness is currently a publicly traded company, in the event that eWellness is delisted and no longer a publicly trading stock, the Monthly Base Fee will automatically revert to $100,000 monthly for any future Monthly Base Fee payments.

 

Section 2. Shares issued to Bistromatics Inc. for existing work completed ($225,000)

 

  - 25,280,899 common shares @$0.0089
   
  - Right to appoint 40% of the Board seats at eWellness

 

It is acknowledged by both Parties that the Company does not currently have enough authorized shares (issued, outstanding and or reserved) to issue Bistromatics 25,280,899 common stock shares. In lieu of this issuance the Parties agree to allow the Company to immediately issue 2,528,089 million shares of a newly authorized Series A Preferred Stock to Bistromatics (the “Series A Preferred Stock”) each share of which shall: (i) have 20 votes per share on all matters submitted to the vote of the holders of eWellness voting capital stock (i.e.: 50,577,980 share voting rights); and (ii) be convertible into 20 shares of eWellness existing shares of common stock. Notwithstanding the foregoing, the Series A Preferred Stock shall not be convertible into shares of common stock, until such time as the Company files a Certificate of Amendment to its Articles of Incorporation to increase itsauthorized shares of common stock from 100 million shares, par value $0.001 per share to 400 million shares, par value $0.0001 per share. At the date of filing the Articles of Amendment, the outstanding shares of Series A Preferred Stock must be converted into 25,280,899 shares of the Company’s common stock.

 

Section 3. Exclusive rights to the Canadian market for all eWellness service and product offerings in perpetuity.

 

- Royalty on revenues of 6% back to eWellness

 

Section 4. All outstanding salaries with eWellness will not be converted by any officer or director. These amounts will still be payable to respective recipients.

 

Section 5. All remaining outstanding expenses at eWellness will still be owed to Darwin Fogt and Curtis Hollister.

 

Section 6. Darwin Fogt, Mike Block and Curtis Hollister shall act as dedicated resources to eWellness through Bistromatics.

 

Section 7.

 

7.1       Term of Agreement and Termination. This Agreement shall expire 90 days from the date it is executed by all Parties hereto. Notwithstanding the foregoing, neither party may terminate this Agreement.

 

7.2       Accurate Information. The Parties hereby represents and warrants that all information provided to both Parties pertaining to PHZIO shall be true, correct and complete to the best of the Parties knowledge.

 

7.3       Dispute Resolution. Disputes between the Parties, under this Agreement or arising from this Agreement, shall be resolved in the following manner: Within thirty (30) days of written notice to the other party, the Parties shall meet and make every good faith effort to resolve the dispute amicable, through direct negotiation. If such direct negotiation is futile or unsuccessful, the Parties, agree to seek an independent mediator, the selection of which shall be mutually agreed upon. Such a mediator shall attempt to find a mutually acceptable resolution to the dispute. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, that cannot be resolved by negotiated resolution, the Parties agree to submit the issues to formal mediation supervised and administered by the Judicial Arbitration and Mediation Services (JAMS). The Parties shall each bear their own legal fees and expenses relating to the mediation, unless, in the opinion of the mediator, the position of one party is merit less, in which event the losing party shall reimburse the prevailing party for such fees and expenses. In the event that Mediation is not successful in reaching a resolution the Parties agree to enter into binding arbitration.

 

2
 

 

7.4       Confidential Information. The Parties acknowledges that, in the course of performing its duties hereunder, it may obtain information relating to the Company that the Company has marked as confidential (“Confidential Information”). Bistromatics shall hold at all times, both during the term of this agreement and at all times thereafter, such Confidential Information in the strictest confidence, and shall not use such Confidential Information for any purpose, other than as may be reasonably necessary for the performance of its duties pursuant to this agreement, without the Company’s prior written consent. Bistromatics shall not disclose any Confidential Information to any person or entity, other than to Consultant’s employees or consultants as may be reasonably necessary for purposes of performing its duties hereunder, without the Company’s prior written consent. The foregoing notwithstanding, the term “Confidential Information” shall not include information which (i) becomes generally available to the public, other than as a result of a breach hereof, (ii) was available on a non-confidential basis prior to its disclosure to Bistromatics by the Company, or (iii) becomes available to Bistromatics on a non-confidential basis from a source other than the Company, provided that such source is not bound by a confidentiality agreement with respect to such information. The foregoing notwithstanding, Bistromatics may disclose Confidential Information to the extent required by law or regulation, including but not limited to court orders, subpoenas, civil investigative demands and interrogatories.

 

7.5       Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Parties hereto and to their respective heirs, representatives, successors-in-interest, beneficiaries and assigns.

 

7.6       Binding Effect. The Parties to this Agreement, each for itself or on behalf of the Party they represent, do hereby represent and warrant that they possess all the authority necessary to enter into this Agreement, and that this Agreement, when duly executed, will constitute a valid, legal and binding agreement, enforceable against themselves in accordance with the terms hereof.

 

7.7       Entire Agreement. This Agreement constitutes the entire agreement and understanding between the Parties and supersedes and replaces all negotiations, and all proposed agreement, whether oral or written between the Parties. The Parties acknowledge that no party nor any of their representatives have made any promise, representation or warranty whatsoever, written or oral, and that the only representations, promises, and covenants made or given are set forth in this Agreement. Accordingly, this Agreement sets forth the entire agreement between the Parties with regard to the subject matter hereof. Further, except as expressly set forth in this Agreement, all agreements, covenants, representations and warranties, express and implied, oral and written, of the Parties with regard to the subject matter hereof, are contained herein.

 

7.8       Waiver, Amendment and Modification. No breach of any provision hereof can be waived unless in writing. Waiver of any one breach of any provision hereof shall not be deemed to be a waiver of any other breach of the same or any other provision hereof. This Agreement may only be amended or modified by an instrument in writing executed by each of the Parties hereto.

 

7.9       Construction. This Agreement shall not be construed against the party preparing it, and shall be construed without regard to the identity of the person who drafted it or the party who caused it to be drafted and shall be construed as if all Parties had jointly prepared this Agreement and it shall be deemed their joint work products, and each and every provision of this Agreement shall be construed as though all of the Parties hereto participated equally in the drafting hereof; and any uncertainty or ambiguity shall not be interpreted against any one party. As a result of the foregoing, any rule of construction that a document is to be construed against the drafting party shall not be applicable.

 

7.10       Governing Law. This Agreement shall be governed in all respects, including validity, interpretation, effect and enforcement, by the laws of the State of California.

 

7.11       Counterparts. This Agreement may be executed in counterparts, each of which, when so executed and delivered, shall be an original; however, such counterparts together shall constitute but one and the same Agreement.

 

7.12       Authority. Each Party represents and warrants that the execution, delivery, and performance by him or it of this Agreement has been duly authorized where such authorization is required, and requires no approval from a third party that has not already been obtained as of the execution date of this Agreement.

 

7.13       Enforceability. Each Settling Party represents and warrants that, when duly executed and delivered, this Agreement shall be valid and binding upon him or it, and shall be fully enforceable against him, her, or it in accordance with its terms.

 

7.14       Interpretation. This Agreement has been jointly negotiated and drafted. The language of this Agreement shall be construed as a whole, according to its fair meaning, and not strictly for or against any Party. Whenever required for proper interpretation, the words in singular shall include the plural and vice versa.

 

(Signatures on Following Page)

 

3
 

 

Date: January 24, 2017

 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement effective as of the day and year above first written.

 

Signatures

 

Bistromatics Inc.  
   
/s/ Curtis Hollister  
Curtis Hollister, Director  

 

eWellness Healthcare Inc.  
   
/s/ Douglas MacLellan  
Douglas MacLellan, Chairman and Director  

 

4